Jingyuan Sun
- Cancer Research top 10%
-
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 3
- Cancer-related gene regulation 3
- Epigenetics and DNA Methylation 2
-
- Cancer Immunotherapy and Biomarkers 6
-
- Skin and Cellular Biology Research 2
-
- Effects and risks of endocrine disrupting chemicals 2
-
- Anesthesia and Neurotoxicity Research 2
- Journals
- Gastroenterology (1 paper)Journal of Hazardous Materials (1 paper)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Jingyuan Sun
23 papers receiving 884 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 296
- Molecular Biology 536
- Ceramics and Composites 43
- Oncology 180
- Immunology 114
Countries citing papers authored by Jingyuan Sun
This map shows the geographic impact of Jingyuan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyuan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyuan Sun more than expected).
Fields of papers citing papers by Jingyuan Sun
This network shows the impact of papers produced by Jingyuan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyuan Sun. The network helps show where Jingyuan Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingyuan Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 36 | |
| 10 | 2020 | 70 | |
| 11 | 2019 | 42 | |
| 12 | 2018 | 118 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 20 | |
| 15 | 2016 | 77 | |
| 16 | 2015 | 15 | |
| 17 | 2014 | 213 | |
| 18 | [miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3]. | 2014 | 4 |
| 19 | 2011 | 19 | |
| 20 | 2010 | 3 |
About Jingyuan Sun
Jingyuan Sun is a scholar working on Developmental Neuroscience, Cancer Research and Oncology, having authored 26 papers that have together received 896 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related gene regulation (3 papers), Skin and Cellular Biology Research (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers), Anesthesia and Neurotoxicity Research (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (296 citations), Molecular Biology (536 citations) and Ceramics and Composites (43 citations). Jingyuan Sun has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Dehua Wu, Chuanhui Cao, Li Liu, Dongyan Zhang, Zhenru Zhu, Xin Li, Xuejun Guo, Liwei Xie, Ze-Qin Guo and H.T. Wu. Their work appears in journals such as Gastroenterology, Journal of Hazardous Materials and Methods in enzymology on CD-ROM/Methods in enzymology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.